HUS1 as a Potential Therapeutic Target in Urothelial Cancer

Platinum-based chemotherapy is the standard of care with concern to first-line systemic therapy for metastatic disease in urothelial cancer (UC). Resistance to chemotherapy despite an initial response is linked with the ability to remove platinum-based DNA adducts and to repair chemotherapy-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindner, Andrea Katharina, Furlan, Tobias, Orme, Jacob J., Tulchiner, Gennadi, Staudacher, Nina, D’Andrea, David, Culig, Zoran, Pichler, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031773/
https://www.ncbi.nlm.nih.gov/pubmed/35456300
http://dx.doi.org/10.3390/jcm11082208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031773/
https://www.ncbi.nlm.nih.gov/pubmed/35456300
http://dx.doi.org/10.3390/jcm11082208

Ejemplares similares